Sarcoma

Patient Perceptions of the Impact of Treatment (Surgery and Radiotherapy) for Soft Tissue Sarcoma

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

An Evaluation of PROMIS Health Domains in Sarcoma Patients Compared to the United States Population

Using the Spleen as an In Vivo Systemic Immune Barometer Alongside Osteosarcoma Disease Progression and Immunotherapy with α-PD-L1

Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size

A Cadaveric Comparative Study on the Surgical Accuracy of Freehand, Computer Navigation, and Patient-Specific Instruments in Joint-Preserving Bone Tumor Resections

Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database

Myxoid Liposarcoma: Treatment Outcomes from Chemotherapy and Radiation Therapy

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy

Periosteal Osteosarcoma: A Single-Institutional Study of Factors Related to Oncologic Outcomes

Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France

Benign Smooth Muscle Tumors (Leiomyomas) of Deep Somatic Soft Tissue

Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy

Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches

The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions

Sarcoma

Table of Contents

Table of Contents

Patient Perceptions of the Impact of Treatment (Surgery and Radiotherapy) for Soft Tissue Sarcoma

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib

An Evaluation of PROMIS Health Domains in Sarcoma Patients Compared to the United States Population

Using the Spleen as an In Vivo Systemic Immune Barometer Alongside Osteosarcoma Disease Progression and Immunotherapy with α-PD-L1

Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size

A Cadaveric Comparative Study on the Surgical Accuracy of Freehand, Computer Navigation, and Patient-Specific Instruments in Joint-Preserving Bone Tumor Resections

Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database

Myxoid Liposarcoma: Treatment Outcomes from Chemotherapy and Radiation Therapy

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy

Periosteal Osteosarcoma: A Single-Institutional Study of Factors Related to Oncologic Outcomes

Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France

Benign Smooth Muscle Tumors (Leiomyomas) of Deep Somatic Soft Tissue

Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy

Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches

The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions